Anti-TRIL functional antibody

Anti-TRIL functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to TRIL/TRIL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0527-Ab-1/ GM-Tg-hg-SE0527-Ab-2Anti-Human TRIL monoclonal antibodyHuman
GM-Tg-rg-SE0527-Ab-1/ GM-Tg-rg-SE0527-Ab-2Anti-Rat TRIL monoclonal antibodyRat
GM-Tg-mg-SE0527-Ab-1/ GM-Tg-mg-SE0527-Ab-2Anti-Mouse TRIL monoclonal antibodyMouse
GM-Tg-cynog-SE0527-Ab-1/ GM-Tg-cynog-SE0527-Ab-2Anti-Cynomolgus/ Rhesus macaque TRIL monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0527-Ab-1/ GM-Tg-felg-SE0527-Ab-2Anti-Feline TRIL monoclonal antibodyFeline
GM-Tg-cang-SE0527-Ab-1/ GM-Tg-cang-SE0527-Ab-2Anti-Canine TRIL monoclonal antibodyCanine
GM-Tg-bovg-SE0527-Ab-1/ GM-Tg-bovg-SE0527-Ab-2Anti-Bovine TRIL monoclonal antibodyBovine
GM-Tg-equg-SE0527-Ab-1/ GM-Tg-equg-SE0527-Ab-2Anti-Equine TRIL monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0527-Ab-1/ GM-Tg-hg-SE0527-Ab-2; GM-Tg-rg-SE0527-Ab-1/ GM-Tg-rg-SE0527-Ab-2;
GM-Tg-mg-SE0527-Ab-1/ GM-Tg-mg-SE0527-Ab-2; GM-Tg-cynog-SE0527-Ab-1/ GM-Tg-cynog-SE0527-Ab-2;
GM-Tg-felg-SE0527-Ab-1/ GM-Tg-felg-SE0527-Ab-2; GM-Tg-cang-SE0527-Ab-1/ GM-Tg-cang-SE0527-Ab-2;
GM-Tg-bovg-SE0527-Ab-1/ GM-Tg-bovg-SE0527-Ab-2; GM-Tg-equg-SE0527-Ab-1/ GM-Tg-equg-SE0527-Ab-2
Products NameAnti-TRIL monoclonal antibody
Formatmab
Target NameTRIL
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TRIL benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0527-Ag-1Recombinant multi-species TRIL protein


    Target information

    Target IDGM-SE0527
    Target NameTRIL
    Gene ID9865,66873,362364,697462,482378,101085452,518003,102148302
    Gene Symbol and Synonyms1200009O22Rik,mKIAA0644,RGD1310827,TRIL
    Uniprot AccessionQ7L0X0,Q496Z2
    Uniprot Entry NameTRIL_HUMAN,TRIL_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000255690
    Target ClassificationN/A

    The target: TRIL, gene name: TRIL, also named as . TRIL is a component of the TLR4 (MIM 603030) complex and is induced in a number of cell types by lipopolysaccharide (LPS) (Carpenter et al., 2009 [PubMed 19710467]).[supplied by OMIM, Apr 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.